SIRT1 and cervical carcinoma: Although these studies [88,89] suggest that SIRT1 may serve as a biomarker for predicting cervical cancer progression, it is not clear if the increased SIRT1 levels are part of a compensatory mechanism attempting to counteract cancer progression.